Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04163952 |
| Title | Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Rutgers, The State University of New Jersey |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | New York | New York | 10016 | United States | Details | |
| New York University Langone Medical Center | New York | New York | 10016 | United States | Details | |
| NYU Langone Medical Center (Tisch Hospital) | New York | New York | 10016 | United States | Details | |
| Duke University Medical Center - Duke Cancer Center | Durham | North Carolina | 27710 | United States | Details |